History
  • No items yet
midpage
EdgePoint Capital Hldgs, LLC v. Apothecare Pharmacy, LLC
6 F.4th 50
| 1st Cir. | 2021
Read the full case

Background

  • EPCH (EdgePoint Capital Holdings, LLC) is an unregistered advisory arm; EPCA is EdgePoint's registered broker-dealer affiliate. EdgePoint sometimes assigned engagements from EPCH to EPCA after work had begun.
  • Apothecare entered a Sell‑Side Agreement in Sept. 2016 naming EdgePoint (signed by EPCH) to market and sell the company; the agreement provided a $350,000+ success fee and an 18‑month "tail" for transactions with "Transactional Partners."
  • EdgePoint prepared a Confidential Information Memorandum that described EPCA (the registered arm) as the company’s advisor, and EPCH contacted several potential buyers (including Clearview) without disclosing Apothecare’s identity.
  • Apothecare terminated the agreement in Aug. 2017; later Clearview and Starboard co‑sponsored a January–July 2018 acquisition of Apothecare.
  • EPCH sued for breach seeking the Success Fee and indemnified attorneys’ fees; district court granted summary judgment to Apothecare, rejecting EPCH’s claims; First Circuit affirmed based on federal securities law grounds.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether the Sell‑Side Agreement is voidable under Exchange Act §29(b) because EPCH (unregistered) induced a securities transaction Contract enforceable; sale might be an asset sale and EPCH could assign contract to registered EPCA, so no securities‑law violation EPCH solicited purchasers for a transaction that expressly contemplated equity (securities) sales; inducement occurred while EPCH was unregistered Held: Agreement voidable under §29(b); EPCH's performance involved attempting to induce a securities transaction, so contract unenforceable
Whether Clearview and Starboard were "Transactional Partners" triggering the tail Success Fee EPCH identified/contacted Clearview and Starboard (so fee due) Listing among many potential buyers or passing mentions insufficient to qualify as identified/contacted Transactional Partners District court held EPCH did not satisfy tail provision; First Circuit affirmed outcome on securities‑law grounds (so EPCH cannot recover)
Whether EPCH may recover attorneys’ fees under the contract indemnity provision EPCH seeks indemnified litigation costs if it prevails Apothecare argues EPCH cannot recover self‑inflicted costs and, here, contract is voidable so indemnity fails Held: EPCH not entitled to fees because contract is voidable under §29(b); district court also found indemnity did not apply to self‑inflicted affirmative claims
Whether a possible assignment to registered EPCA or the possibility of an asset sale provides a safe harbor from registration requirements Assignment/possibility of asset sale means no violation; registration not required during preliminary outreach Registration requirement applies at inducement stage; assigning later does not cure unregistered solicitation of securities Held: Rejected safe‑harbor argument; registration required when soliciting potential purchasers because inducement occurred while unregistered

Key Cases Cited

  • Mills v. Electric Auto‑Lite Co., 396 U.S. 375 (1970) (§29(b) makes offending contracts voidable at the innocent party's option)
  • Berckeley Inv. Grp., Ltd. v. Colkitt, 455 F.3d 195 (3d Cir. 2006) (test for when a contract "involves" a securities violation; violation must be directly related to contract performance)
  • Reg'l Props., Inc. v. Fin. & Real Est. Consulting Co., 678 F.2d 552 (5th Cir. 1982) (§29(b) voids contracts illegal when made or in fact performed; need not be illegal on face)
  • SEC v. Morrone, 997 F.3d 52 (1st Cir. 2021) (assisting issuer to identify potential purchasers can constitute "effecting" transactions)
  • Affco Invs. 2001, LLC v. Proskauer Rose, LLP, 625 F.3d 185 (5th Cir. 2010) (LLC ownership interests can be securities under federal law)
  • Eastside Church of Christ v. Nat'l Plan, Inc., 391 F.2d 357 (5th Cir. 1968) (unregistered broker liability and protections for issuers)
  • Roth v. SEC, 22 F.3d 1108 (D.C. Cir. 1994) (importance of broker‑dealer registration and attendant regulatory duties)
Read the full case

Case Details

Case Name: EdgePoint Capital Hldgs, LLC v. Apothecare Pharmacy, LLC
Court Name: Court of Appeals for the First Circuit
Date Published: Jul 23, 2021
Citation: 6 F.4th 50
Docket Number: 20-1810P
Court Abbreviation: 1st Cir.